Shopping Cart 0
Cart Subtotal
USD 0

Exosome Diagnostics Inc - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Exosome Diagnostics Inc (Exosome Diagnostics) is a provider of diagnostic solutions. The company develops, designs, manufactures and markets biofluid-based molecular diagnostic tests and products for use in personalized medicine. Exosome Diagnostics' services comprise miRNA profiling, mRNA profiling, mutation detection, ribonucleic acid (RNA) sequencing (including full RNA seq) and custom assay development services. The company also offers disease detection, diagnosis, treatment and monitoring. Its technology is used in the treatment of brain cancer, prostate cancer, and Alzheimer's disease. Exosome Diagnostics is headquartered in Waltham, Massachusetts the US.

Exosome Diagnostics Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Exosome Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Exosome Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Exosome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Exosome Diagnostics Inc, Medical Equipment, Deal Details 12

Venture Financing 12

Exosome Diagnostics Raises USD60 Million in Series B Financing Round 12

Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 14

Exosome Diagnostics Raises USD1.5 Million in Financing Round 15

Exosome Diagnostics to Raise USD25 Million in Venture Financing 16

Exosome Diagnostics Raises USD 27 Million In Series B Financing Round 17

Exosome Diagnostics Raises USD 7 Million In Venture Financing 19

Exosome Diagnostics Raises USD3 Million in Venture Financing 20

Partnerships 21

Exosome Diagnostics Enters into Agreement with Intezyne 21

Exosome Diagnostics Enters into Agreement with Merck 22

Exosome Diagnostics Enters into Agreement with Amgen 23

Exosome Diagnostics Enters into Agreement with Takeda Pharma 24

Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 25

Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 26

Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 27

Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 28

Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 29

Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 30

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 31

Acquisition 32

Bio-Techne Acquires Exosome Diagnostics 32

Exosome Diagnostics Inc-Key Competitors 33

Exosome Diagnostics Inc-Key Employees 34

Exosome Diagnostics Inc-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Recent Developments 36

Strategy And Business Planning 36

Aug 01, 2017: Exosome Diagnostics Announces New World Headquarters and Laboratory in Waltham, MA 36

Corporate Communications 37

Mar 21, 2018: Exosome Diagnostics Names Grannum Sant As Head Of Medical Affairs 37

Legal and Regulatory 38

Jun 13, 2018: Exosome Diagnostics Receives ISO 13485:2016 Certification 38

Aug 03, 2017: Exosome Diagnostics Achieves ISO 13485 Certification 39

Jan 18, 2017: Exosome Diagnostics Obtains ISO 15189 for Its Munich Laboratory 40

Product News 41

May 22, 2018: Exosome Diagnostics Announces Bladder Cancer Surveillance Panel 41

May 15, 2018: Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain 42

Apr 17, 2018: Exosome Diagnostics Obviates Tissue Biopsies 43

Oct 11, 2017: Exosome Diagnostics to Present a Novel Atlas of Exosomal mRNA and Long non-coding RNA Across Biofluids at American Society of Exosomes and Microvesicles Annual Meeting 44

Jun 22, 2017: Exosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International Convention 45

Other Significant Developments 46

Aug 24, 2017: CareFirst BlueCross BlueShield and Exosome Diagnostics Announce Evidence Development Collaboration for Molecular Diagnostic Tests 46

Appendix 47

Methodology 47

About GlobalData 47

Contact Us 47

Disclaimer 47


List Of Figure

List of Figures

Exosome Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Exosome Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Exosome Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Exosome Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Exosome Diagnostics Inc, Medical Equipment, Key Facts 2

Exosome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Exosome Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Exosome Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Exosome Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Exosome Diagnostics Inc, Deals By Market, 2012 to YTD 2018 9

Exosome Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Exosome Diagnostics Raises USD60 Million in Series B Financing Round 12

Exosome Diagnostics Raises Additional USD17.6 Million in Series B Financing 14

Exosome Diagnostics Raises USD1.5 Million in Financing Round 15

Exosome Diagnostics to Raise USD25 Million in Venture Financing 16

Exosome Diagnostics Raises USD 27 Million In Series B Financing Round 17

Exosome Diagnostics Raises USD 7 Million In Venture Financing 19

Exosome Diagnostics Raises USD3 Million in Venture Financing 20

Exosome Diagnostics Enters into Agreement with Intezyne 21

Exosome Diagnostics Enters into Agreement with Merck 22

Exosome Diagnostics Enters into Agreement with Amgen 23

Exosome Diagnostics Enters into Agreement with Takeda Pharma 24

Exosome Diagnostics Enters into Agreement with Addario Lung Cancer Medical Institute 25

Qiagen And Exosome Diagnostics Enter Into Agreement To Develop Diagnostics For Cancer Biomarkers 26

Exosome Diagnostics Enters Into Agreement With Eli Lilly To Discover Biomarker 27

Exosome Diagnostics Enters Into Research Agreement With Mount Sinai Hospital 28

Exosome Diagnostics And Qiagen Enter Into Agreement To Develop Line Of Biofluid Nucleic Acid Kits 29

Exosome Diagnostics Enters Into Co-Development Agreement With Promega For Urine Clinical Sample Concentrator Kit 30

Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies 31

Bio-Techne Acquires Exosome Diagnostics 32

Exosome Diagnostics Inc, Key Competitors 33

Exosome Diagnostics Inc, Key Employees 34

Exosome Diagnostics Inc, Subsidiaries 35

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Exosome Diagnostics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.